Use of the ECHO Model to Improve Outcomes for Depressed Patients During the Era of COVID-19

References (5)

1. Taquet M, Geddes JR, Husain M, et al. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8(5):416–427. PubMed CrossRef
2. Vital Statistics at a Glance. Alabama Department of Public Health; 2019. Accessed December 21, 2021. https://www.alabamapublichealth.gov/healthstats/assets/ataglance2019.pdf
3. Residents PAFM. The Quantity, Quality, and Effectiveness of Training on Diagnosing and Treating Mental Disorders. 2018 Annual Meeting of the American Association of Directors of Psychiatry Residency Training; March 1, 2018; New Orleans, LA.
4. Rush AJ, Fava M, Wisniewski SR, et al; STAR*D Investigators Group. Sequenced Treatment Alternatives to Relieve Depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119–142. PubMed CrossRef
5. The University of New Mexico. UNM Health Sciences website. Accessed April 30, 2021. https://hsc.unm.edu/echo/about-us/